Clinical Revision 2

Question 1

What are the key lipids monitoring?

Question 2

What are the key U+E’s monitoring?

Question 3

What are the key features for FBC?

Question 4

What are the key features of ESR?

Question 5

What are the key features of TFTs?

Question 6

What are the key features of LFTs?

Question 7

What are the key features of Lithium levels?

Question 8

What are the key features of digoxin levels?

Question 9

What are the key features of ECG?

Question 10

What are the key features of HbA1c?

Question 11

What are the key features of prolactin?

Question 12

What are the key features of Magnesium?

Question 13

What are the key features of Calcium?

Question 14

What are the key features of monitoring high risk drugs?

Question 15

What are the key features of QRISK?

Question 16

What are the key features of CHADSVASC?

Question 17

What are the key features of CURB65?

Question 18

Explain the process of assessing risks vs benefits of tx.

Question 19

Explain the +/- of NSAIDs use.

Question 20

Explain the +/- of PPI use.

Question 21

Explain the +/- of Anticoagulants use.

Question 22

Explain the +/- of Anticholinergic burden.

Question 23

What are the MHRA warnings of opiates?

Question 24

What are the MHRA warnings of insulin?

Question 25

What are the MHRA warnings of steroids?

Question 26

What are the MHRA warnings of DMARDs?

Question 27

What are the MHRA warnings of anticoagulants - DOAC/Warfarin?

Question 28

What are the MHRA warnings of valproate?

Question 29

Which of the following is incorrect regarding Hyperkalaemia: A: when interpreting a result there’s a need to exclude pseudohyperkalaemia. B: Can cause ECG changes C: Can cause cardiac arrest in severe cases. D: > 6.5mmol should be managed in hospital. E: Can be caused by salbutamol.

Question 30

Which one of the following should be withheld in AKI? A: Enalapril B: Ibuprofen C: Furosemide D: Candesartan E: Aspirin 75mg daily

Question 31

Give e.g. of medications that can be used for anticoagulation.

Question 32

How do each type of anticoagulants differ?

Question 33

What are the +/- of anticoagulants?

Question 34

What are the monitoring requirements for anticoagulants?

Question 35

What is the licensed use for DOACs?

Question 36

What are the LMWH dosing and indications?

Question 37

Explain the differences between asthma/COPD.

Question 38

Which inhaler techniques are used for Asthma/COPD?

Question 39

Explain the management of exacerbations for COPD/Asthma.

Question 40

Explain the safety of antidepressants.

Question 41

Explain the s/e of antidepressants.

Question 42

What are the monitoring requirements for antidepressants?

Question 43

What are the safety risk associated with antipsychotics?

Question 44

What are the s/e of antipsychotics?

Question 45

What are the monitoring requirements for antipsychotics?

Question 46

Explain the pain ladder.

Question 47

What are the +/- of each analgesic classes?

Question 48

Explain the process of opiate dosing.

Question 49

Explain the process of opiate switching.

Question 50

Explain the process of opiate monitoring.

Question 51

Explain the process of opiate Rx with renal function.

Question 52

Explain the process of assessing old px prior to medication.

Question 53

What are the risks of medications of older people?

Question 54

What are the +/- of medication use in older people?

Question 55

Explain the process of de-prescribing.